Published on

CDSCO Manufacturing License for Transcranial electrical stimulation system, continuous- current and pulsed-current

Authors
  • avatar
    Name
    CDSCO Licenses Blog
    Twitter

Introduction

Understanding the significance of regulations and licensing in the medical device industry is of paramount importance. One of the key organisations involved in this process is the Central Drugs Standard Control Organization (CDSCO), the apex drug regulatory body of India. The CDSCO plays a pivotal role in the licensing of manufacturing medical devices. This article specifically focuses on the CDSCO manufacturing license for the Transcranial electrical stimulation system. This device is integral to neurological therapy and treatment of psychiatric disorders such as anxiety, depression, insomnia, and addiction. The CDSCO's portal, which can be found at https://cdscomdonline.gov.in/NewMedDev/Homepage, houses all the essential information pertinent to medical device licenses.

What is a Transcranial Electrical Stimulation System?

A Transcranial Electrical Stimulation System is a device designed to provide continuous or pulsed electrical stimulation to the brain. The system is intended for use in psychiatric and neurological therapies, such as transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS). It induces conditions similar to chemically-induced anaesthesia, providing treatments for anxiety, depression, insomnia, and addiction.

The Role of CDSCO in Medical Device Regulation

The Central Drugs Standard Control Organization (CDSCO) is the cornerstone of medical device regulation in India. It's commitment to ensuring safe, effective, and quality medical products in the market is paralleled with its primary mission of safeguarding public health and welfare. A part of CDSCO's mandate is to oversee the regulatory framework for medical devices, ensuring the proper manufacturing, sale, and distribution of these products.

How to manufacture a Transcranial Electrical Stimulation System

Creating a Transcranial Electrical Stimulation System requires adherence to regulatory guidelines and acquisition of appropriate licenses. In this case, it falls under Risk Class B, necessitating an MD5 license.

Fees for manufacturing license for Transcranial Electrical Stimulation System

As a class B device, the manufacturing license required is MD5, the fee for which is Rs. 5,000, accompanied by an additional Rs. 500 per product.

Why is a Manufacturing License Necessary for Transcranial Electrical Stimulation System?

Attaining a manufacturing license is mandatory and critical for several reasons. It ensures quality and safety in production, in compliance with national regulations. Acquiring a license showcases adherence to regulatory guidelines, thereby safeguarding patient safety from substandard products.

Steps to Obtain a CDSCO Manufacturing License for Transcranial Electrical Stimulation System

The path to license acquisition entails meeting prerequisites, coordinating the necessary documentation—such as the Device Master File, Quality Management Certificate, Device Details, Site details—submitting the application, and navigating through the approval process. Each of these steps is integral and challenging in its right. But with guidance and preparation, the hurdles can be overcome.

Frequently Asked Questions (FAQs)

Q: What is the risk class of Transcranial Electrical Stimulation System as per Medical Device Rules, 2017?

A: The Transcranial Electrical Stimulation System falls under Risk Class B.

Q: What license is needed to manufacture a Transcranial Electrical Stimulation System?

A: The MD5 license is required to manufacture a Transcranial Electrical Stimulation System.

Q: What is the fee for an MD5 license for a Transcranial Electrical Stimulation System?

A: The fee for an MD5 license is Rs. 5,000 plus Rs. 500 per product.

Q: Who will issue the manufacturing license for Transcranial Electrical Stimulation System?

A: For Class B devices such as the Transcranial Electrical Stimulation System, the state FDA will issue the license.

Q: Is repackaging of a Transcranial Electrical Stimulation System considered manufacturing?

A: Yes, as per the Drugs and Cosmetics Act's definition of manufacturing, repackaging of drugs is considered manufacturing. As such, the repackaging of a Transcranial Electrical Stimulation System is considered manufacturing, thereby requiring an MD5 license.

Conclusion

Navigating through the regulatory maze of medical device licensing is a complex process. Seeking professional assistance can make the journey smoother. For tailored guidance and consultation, you are encouraged to reach out to Pharmadocx Consultants. You can connect with them via a call to "+91-7404557227" or send an email to "[email protected]". By associating with Pharmadocx, you can arm yourself with the right expertise to make informed decisions and strategize your approach towards obtaining the MD5 license for the Transcranial Electrical Stimulation System. You can read more about MD5 licenses here.

cdsco import license in india banner
cdsco manufacturing license in india banner